Come up with a name for your new list and we'll add to it:
BioAtla raised a round of funding on January 12, 2016. Investors include
Global BIO Impact Fund.
BioAtla is a global biotechnology company developing novel monoclonal antibody and other protein therapeutic products utilizing our proprietary technologies for product design and development. The com…